Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Moderate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00052936
What this trial is testing

Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
German High-Grade Non-Hodgkin's Lymphoma Study Group 1,506
Post-approval studies (Phase 4)Study completedNCT03778567
What this trial is testing

Renoprotective Effects of Telbivudine in Chronic Hepatitis B

Who this might be right for
Hepatitis B, ChronicChronic Kidney Diseases
The University of Hong Kong 31
Early research (Phase 1)Study completedNCT05560464
What this trial is testing

Evaluation of the Pharmacokinetics and Safety of VX-548 in Participants With Mild or Moderate Hepatic Impairment

Who this might be right for
Pain
Vertex Pharmaceuticals Incorporated 36
Testing effectiveness (Phase 2)Study completedNCT00732498
What this trial is testing

Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL

Who this might be right for
Lymphoma
University of Arizona 28
Early research (Phase 1)Study completedNCT01120314
What this trial is testing

Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild, Moderate and Severe Renal Impairment

Who this might be right for
Renal Impairment
Sanofi 48
Early research (Phase 1)Study completedNCT02240719
What this trial is testing

Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic Cancer

Who this might be right for
Recurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Hodgkin LymphomaRecurrent Grade 1 Follicular Lymphoma+5 more
University of California, Davis 20
Testing effectiveness (Phase 2)Study completedNCT00876863
What this trial is testing

Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Sangamo Therapeutics 49
Testing effectiveness (Phase 2)Ended earlyNCT03170232
What this trial is testing

A Pilot Study of Danirixin for Disease Progression in Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 54
Not applicableStudy completedNCT01233921
What this trial is testing

Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+86 more
Martin, Paul 6
Large-scale testing (Phase 3)Study completedNCT00146211
What this trial is testing

TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease

Who this might be right for
Huntington Disease
Amarin Neuroscience Ltd 300
Testing effectiveness (Phase 2)Study completedNCT01000714
What this trial is testing

Determination of the Efficacy and Safety of Psirelax in the Relief of the Disease in Psoriasis

Who this might be right for
Mild to Moderate Psoriasis
Etwal Ltd.
Early research (Phase 1)Study completedNCT03289234
What this trial is testing

Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Hepatic Impairment

Who this might be right for
Hepatic ImpairmentHealthy
Shionogi 22
Not applicableActive Not RecruitingNCT04567394
What this trial is testing

Cannabis Use Disorder Treatment Study

Who this might be right for
Cannabis Use Disorder, MildCannabis Use Disorder, ModerateCannabis Use Disorder, Severe
The University of Tennessee, Knoxville 1,077
Testing effectiveness (Phase 2)Study completedNCT00112073
What this trial is testing

AAB-001 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 234
Testing effectiveness (Phase 2)Study completedNCT02244541
What this trial is testing

Phase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Anavex Life Sciences Corp. 32
Post-approval studies (Phase 4)Study completedNCT04813354
What this trial is testing

A Comparison of Critical Errors, Overall Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA Versus BREEZHALER Dry Powder Inhalers (DPIs) in Adult Participants With Asthma

Who this might be right for
Asthma
GlaxoSmithKline 114
Not applicableStudy completedNCT06079073
What this trial is testing

The Effect of Orofacial Myofunctional Therapy With Autofeedback on Obstructive Sleep Apnea

Who this might be right for
Sleep Apnea, Obstructive
University Hospital, Akershus 106
Not applicableStudy completedNCT02148354
What this trial is testing

Internet Delivered Intervention Program for the Prevention and Treatment of Depression

Who this might be right for
Internet-based Treatment for Depression
Universitat Jaume I 90
Post-approval studies (Phase 4)Study completedNCT01201122
What this trial is testing

Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis

Who this might be right for
Mild to Moderate Ulcerative Colitis
Wolfson Medical Center 86
Testing effectiveness (Phase 2)Ended earlyNCT03235986
What this trial is testing

InvestigateThe Safety, Tolerability And Efficacy Of Nebulised Curosurf® In Preterm Neonates With Respiratory Distress Syndrome (RDS)

Who this might be right for
Neonatal Respiratory Distress Syndrome
Chiesi Farmaceutici S.p.A. 166
Next Page